Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel Chu
Rachel Chu
Medicine
Intellectual property
B-cell lymphoma
Steroid use
Cancer research
5
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)
2020
Biology of Blood and Marrow Transplantation
Max S. Topp
Tom van Meerten
Roch Houot
Monique C. Minnema
Noel Milpied
Pieternella J. Lugtenburg
Catherine Thieblemont
Martin Wermke
Kevin W. Song
Irit Avivi
John Kuruvilla
Ulrich Dührsen
Rachel Chu
Lianqing Zheng
Vicki Plaks
Anne Kerber
Marie José Kersten
Show All
Source
Cite
Save
Citations (9)
Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma
2019
Blood
Max S. Topp
Tom van Meerten
Roch Houot
Monique C. Minnema
Noel Milpied
Pieternella J. Lugtenburg
Catherine Thieblemont
Martin Wermke
Kevin W. Song
Irit Avivi
John Kuruvilla
Ulrich Dührsen
Rachel Chu
Lianqing Zheng
Vicki Plaks
Anne Kerber
Marie José Kersten
Show All
Source
Cite
Save
Citations (30)
Intellectual Property: Bristol-Myers Squibb and the Medicines Patent Pool – An Unlikely Marriage?
2014
European journal of risk regulation
Rachel Chu
Show All
Source
Cite
Save
Citations (0)
The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings
2011
Journal of Commercial Biotechnology
Meir Perez Pugatch
Rachel Chu
Show All
Source
Cite
Save
Citations (3)
Understanding attitudes to health research or “who can phone you at dinner time?”
2008
Kay Teschke
Rachel Chu
Suhail Marino
Anne Harris
Joseph Ck Tsui
Steve Marion
Show All
Source
Cite
Save
Citations (0)
1